News
eyeDNA plans pivotal trial of retinitis pigmentosa therapy
Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regul
